Forte Biosciences is a biopharmaceutical company focused on autoimmune diseases. Forte’s lead product, FB-102, is a proprietary molecule developed entirely and wholly-owned by Forte Biosciences with potential as a first-in-class biotherapeutic for the treatment of autoimmune diseases. Our initial focus will be on Alopecia Areata, Graft-versus-Host Disease (GVHD)/Transplant Rejection and Vitiligo, large indications with unmet needs.